Page 13 - Lon Gsk News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Lon gsk. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Lon Gsk Today - Breaking & Trending Today

Insider Buying: GSK plc (LON:GSK) Insider Buys £29,379 in Stock

GSK plc (LON:GSK – Get Rating) insider Jonathan Symonds acquired 2,100 shares of the business’s stock in a transaction dated Monday, March 20th. The stock was purchased at an average price of GBX 1,399 ($17.18) per share, with a total value of £29,379 ($36,078.84). GSK Stock Down 0.0 % Shares of LON:GSK opened at GBX […] ....

United Kingdom , United States , Jonathan Symonds , Goldman Sachs Group , Jpmorgan Chase Co , Berenberg Bank , Get Rating , Lon Gsk , Insider Trading , Nsider Trades ,

Deutsche Bank Aktiengesellschaft Analysts Give GSK (LON:GSK) a GBX 1,700 Price Target

Deutsche Bank Aktiengesellschaft set a GBX 1,700 ($20.88) price target on GSK (LON:GSK – Get Rating) in a research note released on Monday, Borsen Zeitung reports. GSK has been the topic of a number of other reports. Jefferies Financial Group set a GBX 1,575 ($19.34) price objective on GSK in a report on Wednesday, February […] ....

United Kingdom , United States , Borsen Zeitung , Emma Walmsley , Jonathan Symonds , Goldman Sachs Group , Jefferies Financial Group , Deutsche Bank Aktiengesellschaft , Company Profile , Credit Suisse Group , Get Rating , Financial Group , Suisse Group , Lon Gsk , Set Price Target ,

GlaxoSmithKline (LON:GSK) Stock Rating Reaffirmed by Deutsche Bank Aktiengesellschaft

GlaxoSmithKline (LON:GSK – Get Rating)‘s stock had its “hold” rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft in a report issued on Tuesday, Marketbeat reports. They presently have a GBX 1,750 ($21.24) target price on the stock. Deutsche Bank Aktiengesellschaft’s price target would indicate a potential upside of 2.48% from the company’s current price. GSK […] ....

United States , United Kingdom , Charles Bancroft , Jefferies Financial Group , Jpmorgan Chase Co , Credit Suisse Group , Deutsche Bank Rese , Deutsche Bank Aktiengesellschaft , Get Rating , Bank Aktiengesellschaft , Financial Group , Bank Rese , Suisse Group , Lon Gsk , Reiterated Rating ,

GlaxoSmithKline's (GSK) "Equal Weight" Rating Reiterated at Barclays

GlaxoSmithKline (LON:GSK – Get Rating)‘s stock had its “equal weight” rating reiterated by Barclays in a research note issued on Monday, Marketbeat.com reports. They presently have a GBX 1,800 ($22.65) target price on the stock. Barclays‘s target price would suggest a potential upside of 4.72% from the stock’s current price. Several other equities analysts have […] ....

United States , United Kingdom , Charles Bancroft , Berenberg Bank , Credit Suisse Group , Deutsche Bank Rese , Deutsche Bank Aktiengesellschaft , Jpmorgan Chase Co , Get Rating , Bank Aktiengesellschaft , Suisse Group , Lon Gsk , Reiterated Rating , Barclays Plc ,

GlaxoSmithKline (LON:GSK) Given a GBX 1,800 Price Target at Barclays

Barclays set a GBX 1,800 ($22.94) target price on GlaxoSmithKline (LON:GSK – Get Rating) in a research report released on Friday, Borsen Zeitung reports. A number of other research firms also recently commented on GSK. The Goldman Sachs Group set a GBX 2,000 ($25.49) target price on GlaxoSmithKline in a research report on Friday, January […] ....

United States , United Kingdom , Emma Walmsley , Charles Bancroft , Borsen Zeitung , Jpmorgan Chase Co , Credit Suisse Group , Goldman Sachs Group , Deutsche Bank Rese , Get Rating , Suisse Group , Lon Gsk , Set Price Target , Barclays Plc ,